patient
met
current
world
health
organ
case
definit
probabl
sar
underw
postmortem
examin
canada
outbreak
includ
studi
clinic
detail
extract
retrospect
hospit
record
clinic
descript
case
publish
separ
may
total
patient
die
sar
canada
die
toronto
patient
autopsi
perform
patient
result
ant
postmortem
examin
routin
bacteri
viral
respiratori
pathogen
patient
describ
elsewher
neg
total
discret
postmortem
lung
sampl
collect
patient
includ
analysi
addit
postmortem
lung
sampl
patient
die
sar
outbreak
whose
death
attribut
caus
also
includ
attribut
caus
death
patient
follow
woman
die
invas
group
streptococc
infect
man
die
congest
heart
failur
man
die
sudden
death
cardiovascular
diseas
man
die
amiodaron
pulmonari
toxic
woman
die
dementia
aspir
pneumonia
woman
die
diabet
congest
heart
failur
man
die
bladder
cancer
aspir
pneumonia
addit
lung
sampl
collect
patient
women
men
age
rang
year
lung
cancer
also
includ
neg
control
sampl
collect
time
autopsi
snap
frozen
mixtur
absolut
ethanol
dri
ice
subsequ
store
test
sampl
code
process
subject
rtpcr
analysi
interpret
ident
sampl
divulg
studi
approv
research
ethic
board
mount
sinai
hospit
univers
health
network
lung
tissu
sampl
thaw
immedi
homogen
lysi
buffer
qiagen
mississauga
canada
dispos
tissu
grinder
kendal
precis
mansfield
homogen
pass
qiashredd
column
qiagen
rna
isol
use
rneasi
mini
kit
qiagen
sampl
elut
rnase
free
water
rtpcr
carri
use
realart
hpacoronaviru
lightcycl
rt
reagent
assay
artu
gmbh
hamburg
germani
lightcycl
realtim
platform
roch
diagnost
laval
canada
hpacoronaviru
master
mix
contain
reagent
enzym
specif
amplif
region
sarscov
polymeras
gene
rna
primer
pair
publish
bernhardnocht
institut
hamburg
germani
post
world
health
organ
web
site
avail
url
http
wwwwhointcsrsarsprimersen
viral
load
calcul
standard
curv
base
four
extern
posit
control
quantif
standard
includ
realart
hpacoronaviru
lightcycl
rt
reagent
assay
kit
figur
b
standard
treat
previous
purifi
sampl
volum
ad
per
capillari
standard
prepar
sarscov
isol
cell
cultur
supernat
cell
use
calibr
run
addit
kit
contain
second
heterolog
amplif
system
ie
intern
control
identifi
either
pcr
inhibit
exclus
ad
extract
rna
rna
isol
qualiti
well
pcr
inhibit
ad
rna
isol
procedur
figur
c
although
assay
insert
state
primer
probe
use
assay
check
possibl
similar
pathogen
mean
sequenc
comparison
randomli
chosen
amplicon
sampl
pool
independ
sequenc
confirm
amplif
detect
univari
analysi
compar
potenti
predictor
viral
load
eg
durat
ill
use
ribavirin
use
steroid
complet
use
fisher
exact
test
twosid
p
valu
consid
signific
clinic
descript
rtpcr
result
patient
probabl
sar
postmortem
lung
tissu
sampl
examin
summar
tabl
mean
age
patient
year
rang
six
patient
men
patient
underli
coexist
condit
common
diabet
mellitu
patient
mean
durat
ill
day
rang
seven
patient
intub
mechan
ventil
death
three
patient
request
intub
inform
ventil
avail
one
patient
ten
patient
treat
ribavirin
patient
treat
steroid
sarscov
detect
postmortem
lung
tissu
sampl
collect
patient
die
diagnosi
probabl
sar
postmortem
lung
sampl
seven
nonsar
fatal
occur
sar
outbreak
neg
sarscov
lungtissu
sampl
collect
patient
lung
cancer
year
outbreak
tabl
correspond
sensit
specif
realart
hpacoronaviru
lightcycl
rt
reagent
assay
confid
interv
ci
sensit
ci
specif
detect
sarscov
sarscov
viral
load
postmortem
lung
tissu
rang
x
copiesg
tissu
x
copiesg
tissu
higher
viral
load
copiesg
tissu
associ
patient
shorter
durat
ill
day
fisher
exact
test
use
ribavirin
steroid
significantli
associ
viral
load
level
tabl
twentyf
randomli
select
amplicon
sampl
pool
sequenc
assess
specif
possibl
crossreact
pathogen
blast
avail
url
http
wwwncbinlmnihgovblast
search
perform
sarscov
genom
genbank
european
molecular
biolog
laboratori
dna
data
bank
japan
protein
data
bank
nation
center
biotechnolog
inform
web
site
avail
url
http
wwwncbinlmnihgov
indic
amplicon
sampl
contain
sarscov
polymeras
gene
sequenc
use
standard
rtpcr
assay
sarscov
unequivoc
identifi
lung
tissu
patient
die
probabl
sar
control
observ
support
primari
role
viru
patient
sar
fatal
outcom
provid
addit
strong
evid
fulfil
koch
postul
regard
sarscov
caus
sar
sarscov
found
differ
lung
sampl
patient
suggest
viru
wide
dissemin
throughout
lung
time
death
previou
studi
suggest
progress
diseas
respiratori
failur
may
primarili
mediat
host
immun
respons
rather
viral
replic
although
viral
rna
lung
tissu
necessarili
indic
replic
viru
viru
multipl
lung
lobe
often
high
copi
number
time
death
suggest
sarscov
may
also
contribut
diseas
progress
fact
higher
viral
load
significantli
associ
patient
shorter
durat
onset
ill
death
support
role
viral
replic
contributor
death
ten
patient
receiv
therapi
ribavirin
patient
treat
steroid
failur
erad
sarscov
despit
ribavirin
therapi
lack
associ
use
ribavirin
sarscov
viral
load
consist
vitro
data
show
ribavirin
activ
agent
global
effort
contain
sar
sever
imped
lack
standard
sensit
specif
diagnost
test
sarscov
differ
diagnost
strategi
includ
cultur
serolog
assay
molecular
detect
method
describ
test
limit
inhous
rtpcr
assay
associ
sensit
low
patient
sar
rais
uncertainti
role
cov
versu
copathogen
mediat
sever
fatal
sar
contrast
sensit
specif
realart
hpacoronaviru
rtpcr
assay
detect
cov
lung
tissu
sampl
appear
excel
addit
realtim
lightcycl
system
assay
gener
quantit
result
within
hour
much
shorter
tradit
pcr
reaction
type
specimen
test
time
sampl
collect
ie
acut
versu
convalesc
phase
method
specimen
collect
well
method
sampl
preserv
may
substanti
impact
result
obtain
diagnost
test
lower
sensit
sarscov
detect
report
peiri
et
al
may
consequ
confound
factor
studi
design
examin
lung
biopsi
clearli
defin
patient
popul
overcam
confound
issu
sampl
techniqu
nonspecif
case
definit
possibl
undocu
exposur
sar
given
predomin
respiratori
symptom
patient
sar
lung
sampl
perhap
highest
viral
titer
specimen
type
yet
nonfat
case
obtain
routin
lung
biopsi
practic
respiratori
tract
specimen
may
satisfactori
substitut
biopsi
studi
examin
preval
sarscov
specimen
type
larger
popul
need
use
standard
commerci
avail
assay
comparison
result
differ
center
may
facilit
